Laporan Laba Rugi (TTM)
Laporan Laba Rugi EUDA Health Holdings Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 12-31 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 5 | 11 | 10 | 10 | 4 | 9 | 8 | 0 | 4 | 3 | 4 | 3 | 4 |
| Change (%) | -48.64 | 131.86 | -0.83 | -3.65 | -62.73 | 135.70 | -14.89 | -98.47 | 3,111.53 | -20.09 | 28.69 | -23.69 | 37.91 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 5 | 3 | 6 | 6 | 6 | 3 | 6 | 5 | 1 | 3 | 2 | 3 | 2 | 3 |
| Change (%) | -33.63 | 87.05 | 4.09 | 0.13 | -55.13 | 120.64 | -15.01 | -83.76 | 225.06 | -19.63 | 29.05 | -20.40 | 37.37 | |
| % of Revenue | 56.17 | 72.58 | 58.55 | 61.46 | 63.86 | 76.89 | 71.97 | 71.87 | 763.52 | 77.28 | 77.73 | 77.95 | 81.32 | 81.00 |
| Gross Operating Profit | 4 | 1 | 4 | 4 | 4 | 1 | 2 | 2 | -1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | -67.87 | 250.48 | -7.78 | -9.66 | -76.16 | 185.81 | -14.58 | -136.05 | -209.96 | -21.68 | 27.44 | -35.35 | 40.26 | |
| % of Revenue | 43.83 | 27.42 | 41.45 | 38.54 | 36.14 | 23.11 | 28.03 | 28.13 | -663.52 | 22.72 | 22.27 | 22.05 | 18.68 | 19.00 |
| SG&A | 5 | 2 | 5 | 6 | 6 | 7 | 10 | 10 | 7 | 5 | 3 | 4 | 2 | 3 |
| Change (%) | -60.87 | 185.66 | 19.66 | -0.28 | 9.42 | 51.74 | -1.70 | -27.90 | -33.84 | -28.41 | 6.88 | -43.60 | 61.21 | |
| % of Revenue | 52.12 | 39.71 | 48.92 | 59.03 | 61.09 | 179.33 | 115.45 | 133.34 | 6,290.45 | 129.59 | 116.10 | 96.42 | 71.27 | 83.31 |
| R&D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | ||||||
| Change (%) | -32.79 | 8.10 | 66.05 | -93.45 | ||||||||||
| % of Revenue | 1.78 | 0.86 | 0.58 | 0.65 | 0.16 | 0.31 | 1.34 | -0.57 | ||||||
| OpEx | 10 | 5 | 11 | 13 | 13 | 15 | 22 | 21 | 13 | 8 | 6 | 7 | 4 | 7 |
| Change (%) | -47.60 | 123.69 | 10.83 | -0.03 | 17.03 | 47.15 | -5.14 | -35.61 | -42.53 | -25.13 | 15.77 | -33.48 | 49.06 | |
| % of Revenue | 110.07 | 112.28 | 108.33 | 121.06 | 125.60 | 394.35 | 246.19 | 274.39 | 11,560.63 | 206.87 | 193.83 | 174.37 | 152.02 | 164.31 |
| Operating Income | -1 | -1 | -1 | -2 | -3 | -11 | -13 | -13 | -13 | -4 | -3 | -3 | -2 | -3 |
| Change (%) | -37.33 | 57.13 | 150.88 | 17.12 | 328.56 | 17.06 | 1.53 | 0.44 | -70.05 | -29.84 | 2.01 | -46.63 | 70.50 | |
| % of Revenue | -10.07 | -12.28 | -8.33 | -21.06 | -25.60 | -294.35 | -146.19 | -174.39 | -11,460.63 | -106.87 | -93.83 | -74.37 | -52.02 | -64.31 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -97.51 | 7,981.21 | -66.55 | -55.73 | 378.09 | 18.76 | -4.15 | -17.95 | -73.49 | 43.50 | 94.76 | -42.36 | 19.97 | |
| % of Revenue | -0.74 | -0.04 | -1.25 | -0.42 | -0.19 | -2.49 | -1.26 | -1.41 | -75.90 | -0.63 | -1.13 | -1.70 | -1.29 | -1.12 |
| Net Income | 0 | 1 | -1 | -2 | -3 | -25 | -28 | -32 | -32 | -10 | -16 | -18 | -17 | -15 |
| Change (%) | 392.57 | -176.79 | 213.43 | 20.49 | 892.22 | 10.60 | 15.40 | 0.07 | -68.41 | 59.76 | 14.43 | -8.16 | -8.89 | |
| % of Revenue | 1.98 | 18.97 | -6.28 | -19.86 | -24.83 | -661.06 | -310.18 | -420.59 | -27,538.87 | -270.86 | -541.53 | -481.52 | -579.52 | -382.88 |
Source: Capital IQ
